Please login to the form below

Not currently logged in
Email:
Password:

tanezumab

This page shows the latest tanezumab news and features for those working in and with pharma, biotech and healthcare.

Pfizer drug gets speedy FDA review for rare heart failure complication

Pfizer drug gets speedy FDA review for rare heart failure complication

products including the company’s Clostridium difficile vaccine and nerve growth factor-targeting tanezumab for severe pain.

Latest news

More from news
Approximately 5 fully matching, plus 13 partially matching documents found.

Latest Intelligence

  • Deal Watch table for November 2013 Deal Watch table for November 2013

    prostate cancer. 2, 400. Pfizer / Lilly. Co-development. Shared development of tanezumab (anti-nerve growth factor) for the treatment of osteoarthritis, chronic low back and cancer pain.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

Partnering with top global pharmaceutical companies, we push the boundaries to create meaningful, impactful and lasting learning opportunities. We leverage...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics